Neurogene Inc. Other Nonoperating Income (Expense)
Neurogene Inc. (NGNE) reported Other Nonoperating Income (Expense) of -$12.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2022-03-01
- Neurogene Inc. other nonoperating income (expense) for the quarter ending 2019-12-31 was $1.00K, a 99.93% decline year-over-year.
- Neurogene Inc. other nonoperating income (expense) for the quarter ending 2019-09-30 was -$9.00K.
- Neurogene Inc. other nonoperating income (expense) for the quarter ending 2019-06-30 was $0.00.
- Neurogene Inc. other nonoperating income (expense) for the quarter ending 2019-03-31 was -$1.00K.
- Neurogene Inc. other nonoperating income (expense) for fiscal 2021 was -$12.00K.
- Neurogene Inc. other nonoperating income (expense) for fiscal 2020 was -$44.00K.
- Neurogene Inc. other nonoperating income (expense) for fiscal 2019 was -$9.00K, a 100.86% decline from fiscal 2018.
- Neurogene Inc. other nonoperating income (expense) for fiscal 2018 was $1.04M, a 10.96% increase from fiscal 2017.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$12.00K 10-K · filed 2022-03-01 | |||||||
| 2020-12-31 | -$44.00K 10-K · filed 2022-03-01 | |||||||
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$8.00K derived: sum of 2 quarters · filed 2021-03-25 | -$8.00K derived: sum of 3 quarters · filed 2021-03-25 | -$9.00K 10-K · filed 2021-03-25 | $1.52M 10-K · filed 2020-03-12 | |||
| 2019-09-30 | -$9.00K 10-Q · filed 2019-11-13 | -$9.00K derived: sum of 2 quarters · filed 2019-11-13 | -$10.00K 10-Q · filed 2019-11-13 | $1.47M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$1.00K 10-Q · filed 2019-08-01 | $1.48M derived: sum of 3 quarters · filed 2020-03-12 | $1.21M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2019-03-31 | -$1.00K 10-Q · filed 2019-05-07 | $1.48M derived: sum of 2 quarters · filed 2020-03-12 | $1.21M derived: sum of 3 quarters · filed 2020-03-12 | $1.09M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.21M derived: sum of 2 quarters · filed 2020-03-12 | $1.10M derived: sum of 3 quarters · filed 2020-03-12 | $1.04M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | -$262.00K 10-Q · filed 2019-11-13 | -$380.00K derived: sum of 2 quarters · filed 2019-11-13 | -$433.00K 10-Q · filed 2019-11-13 | $543.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$118.00K 10-Q · filed 2019-08-01 | -$171.00K 10-Q · filed 2019-08-01 | $805.00K derived: sum of 3 quarters · filed 2020-03-12 | $798.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$53.00K 10-Q · filed 2019-05-07 | $923.00K derived: sum of 2 quarters · filed 2020-03-12 | $916.00K derived: sum of 3 quarters · filed 2020-03-12 | $907.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $969.00K derived: sum of 2 quarters · filed 2020-03-12 | $960.00K derived: sum of 3 quarters · filed 2020-03-12 | $940.00K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$7.00K 10-Q · filed 2018-11-07 | -$16.00K derived: sum of 2 quarters · filed 2018-11-07 | -$36.00K 10-Q · filed 2018-11-07 | $635.00K derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-06-30 | -$9.00K 10-Q · filed 2018-08-08 | $229.00K 10-Q · filed 2017-08-08 | -$29.00K 10-Q · filed 2018-08-08 | $435.00K 10-Q · filed 2017-08-08 | $642.00K derived: sum of 3 quarters · filed 2019-03-07 | $630.00K derived: sum of 4 quarters · filed 2019-03-07 | ||
| 2017-03-31 | -$20.00K 10-Q · filed 2018-05-08 | $206.00K 10-Q · filed 2017-05-09 | $651.00K derived: sum of 2 quarters · filed 2019-03-07 | $639.00K derived: sum of 3 quarters · filed 2019-03-07 | $803.00K derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2016-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $659.00K derived: sum of 2 quarters · filed 2019-03-07 | $823.00K derived: sum of 3 quarters · filed 2019-03-07 | $644.00K 10-K · filed 2019-03-07 | ||||
| 2016-09-30 | -$12.00K 10-Q · filed 2017-11-08 | $137.00K 10-Q · filed 2016-11-09 | $152.00K derived: sum of 2 quarters · filed 2017-11-08 | -$27.00K 10-Q · filed 2017-11-08 | $424.00K 10-Q · filed 2016-11-09 | $205.00K derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | $164.00K 10-Q · filed 2017-08-08 | $287.00K 10-Q · filed 2017-08-08 | $217.00K derived: sum of 3 quarters · filed 2018-03-12 | $99.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $123.00K 10-Q · filed 2017-05-09 | $53.00K derived: sum of 2 quarters · filed 2018-03-12 | -$65.00K derived: sum of 3 quarters · filed 2018-03-12 | -$23.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$188.00K derived: sum of 2 quarters · filed 2018-03-12 | -$146.00K derived: sum of 3 quarters · filed 2018-03-12 | -$520.00K 10-K · filed 2018-03-12 | -$369.00K 10-K · filed 2016-03-14 | |||
| 2015-09-30 | -$118.00K 10-Q · filed 2016-11-09 | -$38.00K 10-Q · filed 2015-11-10 | -$76.00K derived: sum of 2 quarters · filed 2016-11-09 | -$450.00K 10-Q · filed 2016-11-09 | -$365.00K 10-Q · filed 2015-11-10 | $229.00K derived: sum of 4 quarters · filed 2017-03-09 | ||
| 2015-06-30 | $42.00K 10-Q · filed 2016-08-04 | $34.00K 10-Q · filed 2015-08-06 | -$330.00K 10-Q · filed 2016-08-04 | -$326.00K 10-Q · filed 2015-08-06 | $347.00K derived: sum of 3 quarters · filed 2017-03-09 | $346.00K derived: sum of 4 quarters · filed 2017-03-09 | ||
| 2015-03-31 | -$373.00K 10-Q · filed 2016-05-10 | -$360.00K 10-Q · filed 2015-05-12 | $305.00K derived: sum of 2 quarters · filed 2017-03-09 | $304.00K derived: sum of 3 quarters · filed 2017-03-09 | $500.00K derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2014-12-31 | $678.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $677.00K derived: sum of 2 quarters · filed 2017-03-09 | $873.00K derived: sum of 3 quarters · filed 2017-03-09 | $683.00K 10-K · filed 2017-03-09 | -$254.89K 10-K · filed 2015-03-16 | |||
| 2014-09-30 | -$1.00K 10-Q · filed 2015-11-10 | $195.00K derived: sum of 2 quarters · filed 2015-11-10 | $5.00K 10-Q · filed 2015-11-10 | |||||
| 2014-06-30 | $196.00K 10-Q · filed 2015-08-06 | $6.00K 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | -$189.00K 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | $109.00K 10-K · filed 2016-03-14 | $108.94K 10-K · filed 2015-03-16 | ||||||
| 2012-12-31 | $64.03K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |